000 | 01098 a2200301 4500 | ||
---|---|---|---|
005 | 20250514062139.0 | ||
264 | 0 | _c20030711 | |
008 | 200307s 0 0 eng d | ||
022 | _a0890-9091 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNabhan, Chadi | |
245 | 0 | 0 |
_aCurrent status of monoclonal antibody therapy for chronic lymphocytic leukemia. _h[electronic resource] |
260 |
_bOncology (Williston Park, N.Y.) _cFeb 2003 |
||
300 |
_a253-62; discussion 264, 267, passim p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xdiagnosis |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aPrognosis |
700 | 1 | _aDyer, Martin J | |
700 | 1 | _aRosen, Steven T | |
773 | 0 |
_tOncology (Williston Park, N.Y.) _gvol. 17 _gno. 2 _gp. 253-62; discussion 264, 267, passim |
|
999 |
_c12427691 _d12427691 |